Market Entry Agreements for Innovative Pharmaceuticals Subject to Indication Broadening: A Case Study for Pembrolizumab in The Netherlands
| Autor: | Heine, Renaud J.S.D., Mathijssen, Ron H.J., Verbeek, Floor A.J., Van Gils, Chantal, Uyl-de Groot, Carin A. |
|---|---|
| Zdroj: | In Value in Health October 2024 27(10):1367-1372 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect